SCHEMBL18362124

SCHEMBL18362124

NCc1cc(NCc2cccc(C(=O)N3CCN(c4ccccc4)CC3)c2)ncn1

nearest known ligand 0.98

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 4/20 0.98
LMNA P02545 4/20 0.52
MAPT P10636 2/20 0.52
MAPK1 P28482 2/20 0.52
TSHR P16473 2/20 0.52
USP2 O75604 1/20 0.52
PARP1 P09874 2/20 0.49
KDM1A O60341 1/20 0.48
ALDH1A1 P00352 2/20 0.46
ALOX15 P16050 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
ALOX12 P18054 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SLC6A7 Q99884 1/20 0.44
JAK3 P52333 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20337902 0.99 LOXL2 (1.00) LOXL2LMNAMAPTMAPK1TSHR
SCHEMBL20348544 0.85 LOXL2 (0.72) LOXL2LMNAMAPTMAPK1TSHR
SCHEMBL18362022 0.82 LOXL2 (0.68) LOXL2LMNAMAPTMAPK1TSHR
Hydrochloric Acid SCHEMBL20337983 0.81 LOXL2 (0.70) LOXL2LMNAMAPTMAPK1TSHR
SCHEMBL18362112 0.77 LOXL2 (0.85) LOXL2JAK3
SCHEMBL18362029 0.77 LOXL2 (0.61) LOXL2LMNAMAPTMAPK1TSHR
Hydrochloric Acid SCHEMBL20337929 0.76 LOXL2 (0.86) LOXL2JAK3
SCHEMBL18361809 0.75 LOXL2 (0.63) LOXL2TSHRALDH1A1MEN1KMT2A
SCHEMBL20337961 0.75 LOXL2 (0.59) LOXL2LMNAMAPTMAPK1TSHR
SCHEMBL18362065 0.74 LOXL2 (0.67) LOXL2LMNAMAPTMAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180186755-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA INC (US) 2018-07-05 US claimed
EP-3510404-A1 CHEMICAL PROBES OF LYSYL OXIDASE-LIKE 2 AND USES THEREOF Pharmakea, Inc. (US) 2019-07-17 EP disclosed
US-20190192697-A1 CHEMICAL PROBES OF LYSYL OXIDASK-LIKE 2 AND USES THEREOF PHARMAKEA, INC. 2019-06-27 US disclosed
US-20180186755-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA INC (US) 2018-07-05 US disclosed
US-20180186755-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA INC (US) 2018-07-05 US disclosed
US-20180186755-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA INC (US) 2018-07-05 US disclosed
WO-2018048928-A1 CHEMICAL PROBES OF LYSYL OXIDASE-LIKE 2 AND USES THEREOF PHARMAKEA, INC. (US) 2018-03-15 WO disclosed
WO-2017003862-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2017-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180186755-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF LOXL2, LOXL1, LOX LOXL2 1/4885LMNA 179/4885MAPT 3741/4885
US-20190192697-A1 CHEMICAL PROBES OF LYSYL OXIDASK-LIKE 2 AND USES THEREOF LOXL2, LOXL1, LOXL3 LOXL2 1/4885LMNA 1626/4885MAPT 4698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.